[(2~{S})-3-[[(2~{S})-1-azanyl-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-2-[[3-(2-hydroxyphenyl)-1,2-oxazol-5-yl]methyl]-3-oxidanylidene-propyl]-[(1~{R})-1-azanyl-3-phenyl-propyl]phosphinic acid

InChIKey	`GSWUIYHGTPVQDP-FNHKZSGOSA-N`
Compound Name	[(2~{S})-3-[[(2~{S})-1-azanyl-1-oxidanylidene-3-phenyl-propan-2-yl]amino]-2-[[3-(2-hydroxyphenyl)-1,2-oxazol-5-yl]methyl]-3-oxidanylidene-propyl]-[(1~{R})-1-azanyl-3-phenyl-propyl]phosphinic acid
Canonical SMILES	`NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1cc(-c2ccccc2O)no1)CP(=O)(O)[C@@H](N)CCc1ccccc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Homologous
Avg pChEMBL	7.44
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q9UIQ6	LNPEP	Homo sapiens	Human	PF11838 PF01433 PF17900	8.1	IC50	ChEMBL;BindingDB
Q9NZ08	ERAP1	Homo sapiens	Human	PF11838 PF01433 PF17900	7.2	IC50	ChEMBL;BindingDB
Q6P179	ERAP2	Homo sapiens	Human	PF11838 PF01433 PF17900	7.1	IC50	ChEMBL;BindingDB